Rare disease leader and international pharmaceutical company Shire Pharmaceuticals has opened a new London office in Paddington.
Shire's new office will become a centre for their UK-based employees to strengthen their relationships with stakeholders in academic research, clinical practice, regulatory affairs and medical innovation.
Operating in the UK for 30 years, Shire is now the leading global biotechnology company focused on serving people with rare diseases and highly specialised conditions.
One in 17 people living in the UK will be affected by a rare disease at some point in their life and 75% of those with a rare disease are children.
Rajesh Agrawal, deputy mayor of London for business, said: “London is one of the greatest scientific cities in the world and has been at the forefront of medical discovery and innovation for hundreds of years.
“I am delighted that Shire has chosen the capital for its new UK base as they look to develop treatments for some of the world’s rarest diseases.
"Shire clearly recognise that London is a world-leading hub for life sciences and their decision to move here is a boost for this important sector of our economy.”